CPAEX | QLEIX | CPAEX / QLEIX | |
Total Expense Ratio | 2.03 | 5.33 | 38% |
Annual Report Gross Expense Ratio | 1.92 | 5.33 | 36% |
Fund Existence | 10 years | 12 years | - |
Gain YTD | 2.960 | 15.605 | 19% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 5000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 423M | 4.96B | 9% |
Annual Yield % from dividends | 0.07 | 6.18 | 1% |
Returns for 1 year | 12.45 | 26.26 | 47% |
Returns for 3 years | 39.95 | 79.14 | 50% |
Returns for 5 years | 119.07 | 184.97 | 64% |
Returns for 10 years | N/A | 155.55 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CSHNX | 11.52 | 0.06 | +0.52% |
NYLI Cushing® MLP Premier Investor Class | |||
RAGHX | 26.47 | -0.19 | -0.71% |
Virtus KAR Health Sciences A | |||
AYBLX | 11.36 | -0.10 | -0.87% |
Victory Pioneer Balanced Y | |||
CWICX | 68.31 | -0.73 | -1.06% |
American Funds Capital World Gr&Inc 529C | |||
GCTSX | 46.18 | -0.60 | -1.28% |
Goldman Sachs US Tax-Managed Eq Svc |